Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · September 04, 2018

Adjuvant Sunitinib in Patients With High-Risk Renal Cell Carcinoma

Annals of Oncology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Annals of Oncology
Adjuvant Sunitinib in Patients With High-Risk Renal Cell Carcinoma: Safety, Therapy Management, and Patient-Reported Outcomes in the S-TRAC Trial
Ann. Oncol 2018 Aug 23;[EPub Ahead of Print], M Staehler, RJ Motzer, DJ George, HS Pandha, F Donskov, B Escudier, AJ Pantuck, A Patel, L DeAnnuntis, H Bhattacharyya, K Ramaswamy, G Zanotti, X Lin, M Lechuga, L Serfass, J Paty, A Ravaud

Further Reading